The combination of glycolytic inhibitor 2-deoxyglucose and microbubbles increases the effect of 5-aminolevulinic acid-sonodynamic therapy in liver cancer cells
Ultrasound in Medicine and Biology Aug 29, 2017
Xie R, et al. – Researchers deliberated that the combination of 2–deoxyglucose (2–DG) and microbubbles (MBs) will increase the effect of 5–aminolevulinic acid (ALA)–sonodynamic therapy in HepG2 liver cancer cells. This study demonstrates a promising therapeutic strategy applying a combination of 2–DG, MBs and ALA–SDT for treating liver cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
